Pulmonary adenocarcinoma shown as groundglass nodule: radiology, histopathology and molecular biology characteristics

doi:10.3760/cma.j.issn.1673-422X.2018.10.011

Abstract

Abstract: With multi-slice spiral CT widely used in lung cancer screening, groundglass nodule (GGN) has also received extensive attention. In addition to benign disease, GGN may also be a special manifestation of early lung adenocarcinoma and its precancerous lesions. Therefore, investigation of the correlation between CT imaging features of GGN and pathological subtypes or molecular biology of lung adenocarcinoma is of great significance in guiding clinical diagnosis and treatment.

Key words: Lung neoplasms, Tomography, spiral computed, Ground glass nodule, Gene mutation

Ma Yi, Xu Shun. Pulmonary adenocarcinoma shown as groundglass nodule: radiology, histopathology and molecular biology characteristics[J]. Journal of International Oncology, 2018, 45(10): 627-631.

References

［1］ Miao Y, Zhang J, Zou J, et al. Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma［J］. Transl Lung Cancer Res, 2017, 6(1): 14-22. DOI: 10.21037/tlcr.2017.02.06. ［2］赵悦, 王瑞, 陈海泉. 肺部磨玻璃影的诊断与治疗进展［J］. 中国肺癌杂志, 2016, 19(11): 773-777. DOI: 10.3779/j.issn.10093419.2016.11.09. ［3］ Pedersen JH, Saghir Z, Wille MM, et al. Groundglass opacity lung nodules in the era of lung cancer CT screening: radiology, pathology, and clinical management［J］. Oncology (Williston Park), 2016, 30(3): 266274. ［4］ Lee HY, Choi YL, Lee KS, et al. Pure groundglass opacity neoplastic lung nodules: histopathology, imaging, and management［J］. AJR Am J Roentgenol, 2014, 202(3): W224-W233. DOI: 10.2214/AJR.13.11819. ［5］ Travis WD, Asamura H, Bankier AA, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in partsolid tumors in the forthcoming eighth edition of the TNM classification of lung cancer［J］. J Thorac Oncol, 2016, 11(8): 1204-1223. DOI: 10.1016/j.jtho.2016.03.025. ［6］ Eguchi T, Yoshizawa A, Kawakami S, et al. Tumor size and computed tomography attenuation of pulmonary pure groundglass nodules are useful for predicting pathological invasiveness［J］. PLoS One, 2014, 9(5): e97867. DOI: 10.1371/journal.pone.0097867. ［7］高丰, 葛虓俊, 李铭, 等. 不同病理类型肺部磨玻璃结节的CT诊断［J］. 中华肿瘤杂志, 2014, 36(3): 188-192. DOI: 10.3760/cma.j.issn.0253-3766.2014.03.006. ［8］ Qiu ZX, Cheng Y, Liu D, et al. Clinical, pathological, and radiological characteristics of solitary groundglass opacity lung nodules on highresolution computed tomography［J］. Ther Clin Risk Manag, 2016, 12: 1445-1453. DOI: 10.2147/TCRM.S110363. ［9］ Zhang Y, Qiang JW, Ye JD, et al. High resolution CT in differentiating minimally invasive component in early lung adenocarcinoma［J］. Lung cancer, 2014, 84(3): 236-241. DOI: 10.1016/j.lungcan.2014.02.008. ［10］ Gao JW, Rizzo S, Ma LH, et al. Pulmonary groundglass opacity: computed tomography features, histopathology and molecular pathology［J］. Transl Lung Cancer Res, 2017, 6(1): 68-75. DOI: 10.21037/tlcr.2017.01.02. ［11］ Kitami A, Sano F, Hayashi S, et al. Correlation between histological invasiveness and the computed tomography value in pure groundglass nodules［J］. Surg Today, 2016, 46(5): 593-598. DOI: 10.1007/s00595-015-1208-1. ［12］ Liu LH, Liu M, Wei R, et al. CT findings of persistent pure ground glass opacity: can we predict the invasiveness?［J］. Asian Pac J Cancer Prev, 2015, 16(5): 1925-1928. ［13］ Lee SM, Park CM, Goo JM, et al. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as groundglass nodules: differentiation by using CT features［J］. Radiology, 2013, 268(1): 265-273. DOI: 10.1148/radiol.13120949. ［14］南静. 多层螺旋CT在肺内≤1 cm纯磨玻璃结节浸润性腺癌与浸润前病变鉴别诊断中的价值［J］. 国际肿瘤学杂志, 2017, 44(8): 573-577. DOI: 10.3760/cma.j.issn.1673-422X.2017.08.004. ［15］ Lee SM, Goo JM, Lee KH, et al. CT findings of minimally invasive adenocarcinoma (MIA) of the lung and comparison of solid portion measurement methods at CT in 52 patients［J］. Eur Radiol, 2015, 25(8): 2318-2325. DOI: 10.1007/s00330-015-3616-4. ［16］ Moon Y, Sung SW, Lee KY, et al. Pure groundglass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma［J］. J Thorac Dis, 2016, 8(7): 1561-1570. DOI: 10.21037/jtd.2016.06.34. ［17］ Mao H, Labh K, Han F, et al. Diagnosis of the invasiveness of lung adenocarcinoma manifesting as ground glass opacities on highresolution computed tomography［J］. Thoracic cancer, 2016, 7(1): 129-135. DOI: 10.1111/1759-7714.12269. ［18］ Hwang EJ, Park CM, Ryu Y, et al. Pulmonary adenocarcinomas appearing as partsolid groundglass nodules: is measuring solid component size a better prognostic indicator?［J］. Eur Radiol, 2015, 25(2): 558-567. DOI: 10.1007/s00330-014-3441-1. ［19］ Matsunaga T, Suzuki K, Takamochi K. What is the radiological definition of partsolid tumour in lung cancer?［J］. Eur J Cardiothorac Surg, 2017, 51(2): 242-247. DOI: 10.1093/ejcts/ezw344. ［20］ Sakakura N, Inaba Y, Yatabe Y, et al. Estimation of the pathological invasive size of pulmonary adenocarcinoma using highresolution computed tomography of the chest: a consideration based on lung and mediastinal window settings［J］. Lung cancer, 2016, 9(5): 51-56. DOI: 10.1016/j.lungcan.2016.02.017. ［21］ Asamura H, Hishida T, Suzuki K, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201［J］. J Thorac Cardiovasc Surg, 2013, 146(1): 24-30. DOI: 10.1016/j.jtcvs.2012.12.047. ［22］ Hattori A, Matsunaga T, Takamochi K, et al. Importance of ground glass opacity component in clinical stage ⅠA radiologic invasive lung cancer［J］. Ann Thorac Surg, 2017, 104(1): 313-320. DOI: 10.1016/j.athoracsur.2017.01.076. ［23］ Li Z, Ye B, Bao M, et al. Radiologic predictors for clinical stage ⅠA lung adenocarcinoma with ground glass components: a multicenter study of longterm outcomes［J］. PLoS One, 2015, 10(9): e0136616. DOI: 10.1371/journal.pone.0136616. ［24］ Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thinsection computed tomography to predict pathological noninvasiveness in peripheral clinical ⅠA lung cancer (Japan Clinical Oncology Group 0201)［J］. J Thorac Ooncol, 2011, 6(4): 751-756. DOI: 10.1097/JTO.0b013e31821038ab. ［25］ Duann CW, Hung JJ, Hsu PK, et al. Surgical outcomes in lung cancer presenting as groundglass opacities of 3 cm or less: a review of 5 years′ experience［J］. J Chin Med Assoc, 2013, 76(12): 693-697. DOI: 10.1016/j.jcma.2013.08.005. ［26］ Yamaguchi M, Furuya A, Edagawa M, et al. How should we manage small focal pure groundglass opacity nodules on highresolution computed tomography? A single institute experience［J］. Surg Oncol, 2015, 24(3): 258-263. DOI: 10.1016/j.suronc.2015.08.004. ［27］ Tsao MS, Marguet S, Le Teuff G, et al. Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection［J］. J Clin Oncol, 2015, 33(30): 3439-3446. DOI: 10.1200/JCO.2014.58.8335. ［28］ National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines for Lung Cancer Screening.Version 1. 2017［EB/OL］. United States, NCCN, 2016-08-10. https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf ［29］ Cao C, Gupta S, Chandrakumar D, et al. Metaanalysis of intentional sublobar resections versus lobectomy for early stage nonsmall cell lung cancer［J］. Ann Cardiothorac Surg, 2014, 3(2): 134-141. DOI: 10.3978/j.issn.2225319X.2014.03.08. ［30］ Deng HY, Wang YC, Ni PZ, et al. Radiotherapy, lobectomy or sublobar resection? A metaanalysis of the choices for treating stage Ⅰ nonsmallcell lung cancer［J］. Eur J Cardiothorac Surg, 2017, 51(2): 203-210. DOI: 10.1093/ejcts/ezw272. ［31］ Taioli E, Yip R, Olkin I, et al. Survival after sublobar resection for earlystage lung cancer: methodological obstacles in comparing the efficacy to lobectomy［J］. J Thorac Oncol, 2016, 11(3): 400-406. DOI: 10.1016/j.jtho.2015.10.022. ［32］ Rizzo S, Petrella F, Buscarino V, et al. CT radiogenomic characterization of EGFR, KRAS, and ALK mutations in nonsmall cell lung cancer［J］. Eur Radiol, 2016, 26(1): 32-42. DOI: 10.1007/s0033001538140. ［33］ Liu Y, Kim J, Qu F, et al. CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma［J］. Radiology, 2016, 280(1): 271-280. DOI: 10.1148/radiol.2016151455. ［34］ Cheng Z, Shan F, Yang Y, et al. CT characteristics of nonsmall cell lung cancer with epidermal growth factor receptor mutation: a systematic review and metaanalysis［J］. BMC Med Imaging, 2017, 17(1): 5. DOI: 10.1186/s1288001601753. ［35］ Hong SJ, Kim TJ, Choi YW, et al. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: imaging features and histological subtypes［J］. Eur Radiol, 2016, 26(10): 36603668. DOI: 10.1007/s003300154196z. ［36］ Lee HJ, Kim YT, Kang CH, et al. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes［J］. Radiology, 2013, 268(1): 254264. DOI: 10.1148/radiol.13112553. ［37］ Yang Y, Yang Y, Zhou X, et al. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant groundglass opacity［J］. Lung Cancer, 2015, 87(3): 272-277. DOI: 10.1016/j.lungcan.2014.12.016. ［38］ Ko SJ, Lee YJ, Park JS, et al. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular groundglass opacity［J］. BMC Cancer, 2014, 14: 312. DOI: 10.1186/1471240714312. ［39］ Zhou JY, Zheng J, Yu ZF, et al. Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations［J］. Eur Radiol, 2015, 25(5): 12571266. DOI: 10.1007/s003300143516z. ［40］ Aoki T, Hanamiya M, Uramoto H, et al. Adenocarcinomas with predominant groundglass opacity: correlation of morphology and molecular biomarkers［J］. Radiology, 2012, 264(2): 590-596. DOI: 10.1148/radiol.12111337. ［41］ Kobayashi Y, Mitsudomi T, Sakao Y, et al. Genetic features of pulmonary adenocarcinoma presenting with groundglass nodules: the differences between nodules with and without growth［J］. Ann Oncol, 2015, 26(1): 156-161. DOI: 10.1093/annonc/mdu505. ［42］ Liu M, He WX, Song N, et al. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple groundglass opacities［J］. Eur J Cardiothorac Surg, 2016, 50(5): 909-913. DOI: 10.1093/ejcts/ezw113. ［43］ Wu C, Zhao C, Yang Y, et al. High discrepancy of driver mutations in patients with NSCLC and synchronous multiple lung groundglass nodules［J］. J Thorac Oncol, 2015, 10(5): 778-783. DOI: 10.1097/JTO.0000000000000487. ［44］ Wang T, Zhang T, Han X, et al. Impact of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage ⅠA adenocarcinoma of the lung: correlation between computed tomography images and EGFR and KRAS gene mutations［J］. Exp Ther Med, 2015, 9(6): 20952103. DOI: 10.3892/etm.2015.2422.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	He Jiahui, Hu Qinyong. Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data [J]. Journal of International Oncology, 2024, 51(1): 29-36.
[3]	Li Bin, Zhang Guifang, Zhou Linjing, Yang Xiaodong, He Qiuli, Jia Sisi, Huang Puchao, Liang Jiaxin. Relationships between PIK3CA gene status and clinical features and prognosis in triple-negative breast cancer [J]. Journal of International Oncology, 2023, 50(5): 263-267.
[4]	Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng. Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection [J]. Journal of International Oncology, 2023, 50(12): 711-716.
[5]	Chen Yu, Xu Hua, Liu Hai, Chen Shixin. Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging [J]. Journal of International Oncology, 2023, 50(11): 655-660.
[6]	Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun. Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model [J]. Journal of International Oncology, 2022, 49(9): 532-536.
[7]	Wu Jiayu, Liu Jiacheng. Research progress of radiomics toward lung adenocarcinoma manifesting as solitary ground glass nodule [J]. Journal of International Oncology, 2022, 49(8): 449-452.
[8]	Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying. Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses [J]. Journal of International Oncology, 2022, 49(8): 459-463.
[9]	Cai Gangxiang, Li Jing, Xu Bin. Advances in neoadjuvant immunotherapy for lung cancer [J]. Journal of International Oncology, 2022, 49(6): 366-370.
[10]	Zhang Jingxian, Yi Dan, Li Xiaojiang. Application of antibody-drug conjugates in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(5): 296-301.
[11]	Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei. Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer [J]. Journal of International Oncology, 2022, 49(4): 247-251.
[12]	Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu. Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(3): 140-145.
[13]	Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming. Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(2): 111-115.
[14]	Huang Huayu, Song Qibin, Gong Hongyun, Song Jia. Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy [J]. Journal of International Oncology, 2022, 49(12): 718-723.
[15]	Zhang Hongjiao, Jiang Jie, Huang Wei. Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis [J]. Journal of International Oncology, 2022, 49(1): 51-55.